Radiosynovectomy: Review of the literature and report from two haemophilia treatment centers

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 5, 2013, Pages 465-470

  Rampersad, Angeli G ^a   Shapiro, Amy D ^a   Rodriguez Merchan, E Carlos ^b   Maahs, Jennifer A ^a   Akins, Stacie ^a   Jimenez Yuste, Victor ^b  

^a INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Arthroscopic; chemical; haemophilia; radiosynovectomy; synovectomy; synovitis

Indexed keywords

ANTIINFLAMMATORY AGENT; BLOOD CLOTTING FACTOR 8 INHIBITOR; ERBIUM 169; GOLD 198; OXYTETRACYCLINE; PHOSPHORUS 32; RHENIUM 186; RIFAMPICIN; YTTRIUM 90;

ARTHROPATHY; ARTHROSCOPY; ARTICULAR CARTILAGE; BONE DESTRUCTION; CANCER RISK; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; GENOTOXICITY; HEALTH CENTER; HEMOPHILIA; HUMAN; MEDICAL RECORD REVIEW; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOLOGICAL PROCEDURES; RETROSPECTIVE STUDY; REVIEW; SKIN NECROSIS; SPAIN; SWELLING; SYNOVECTOMY; SYNOVITIS; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; CHILD; HEMOPHILIA A; HUMANS; INDIANA; JOINT DISEASES; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; PHOSPHORUS RADIOISOTOPES; RADIOISOTOPES; RADIOSURGERY; RHENIUM; SPAIN; SYNOVITIS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84879894829     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283602a28     Document Type: Review

References (43)

1. Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker M, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357:535-544.
2. Rodriguez-Merchan E. Musculoskeletal complications of hemophilia. Hospital Special Surg J 2010; 6:37-42.
3. Roosendaal G, Lafeber F. Pathogenesis of haemophilic arthropathy. Haemophilia 2006; 12:117-121.
4. Dunn AL. Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia. Haemophilia 2011; 17:571-578.
5. Hoots WK, Rodriguez N, Boggio L, Valentino LA. Pathogenesis of haemophilic synovitis: clinical aspects. Haemophilia 2007; 13 (Suppl 3): 4-9.
6. Valentino LA, Hakobyan N, Rodriguez N, Hoots WK. Pathogenesis of haemophilic synovitis: experimental studies on blood-induced joint damage. Haemophilia 2007; 13 (Suppl 3):10-13.
7. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, Subcommittee FVa FI. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85:560.
8. Astermark J. Overview of inhibitors. Semin Hematol 2006; 43:S3-S7.
9. Key NS. Inhibitors in congenital coagulation disorders. Br J Haematol 2004; 127:379-391.
10. Soucie JM, Cianfrini C, Janco R, Kulkarni R, Hambleton J, Evatt BL, et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and riskfactors. Blood 2004; 103:2467-2473.
11. Morfini M. Articular status of haemophilia patients with inhibitors. Haemophilia 2008; 14(Suppl 6):20-22.
12. Manco-Johnson MJ, Nuss R, Lear J, Wiedel J, Geraghty SJ, Hacker MR, et al. 32P Radiosynoviorthesis in children with hemophilia. J Pediatr Hematol/Oncol 2002; 24:534-539.
13. Silva M, Luck JV Jr, Siegel ME. 32P chromic phosphate radiosynovectomy for chronic haemophilic synovitis. Haemophilia 2001; 7 (Suppl 2): 40-49.
14. Nuss R, Kilcoyne RF, Rivard GE, Murphy J. Late clinical, plain X-ray and magnetic resonance imaging findings in haemophilicjoints treated with radiosynoviorthesis. Haemophilia 2000; 6:658-663.
15. Rodriguez-Merchan EC Methods to treat chronic haemophilic synovitis. Haemophilia 2001; 7:1-5.
16. Mathew P, Talbut DC, Frogameni A, Singer D, Chrissos M, Khuder S, et al. Isotopic synovectomy with P-32 in paediatric patients with haemophilia. Haemophilia 2000; 6:547-555.
17. Heim M, Goshen E, Amit Y, Martinowitz U. Synoviorthesis with radioactive Yttrium in haemophilia: Israel experience. Haemophilia 2001; 7 (Suppl 2): 36-39.
18. Rodriguez-Merchan EC, Jimenez-Yuste V, Villar A, Quintana M, Lopez-Cabarcos C, Hernandez-Navarro F. Yttrium-90 synoviorthesis for chronic haemophilic synovitis: Madrid experience. Haemophilia 2001; 7 (Suppl 2): 34-35.
19. Rodráguez-Merchán EC, Magallón M, Galindo E, López-Cabarcos C. Hemophilic synovitis of the knee and the elbow. Clin Orthop Relat Res 1997; 343: 47-53.
20. Rodriguez-Merchan EC, Goddard NJ. The technique of synoviorthesis. Haemophilia 2001; 7 (Suppl 2):11-15.
21. Rodriguez-Merchan EC, Quintana M, De la Corte-Rodriguez H, Coya J. Radioactive synoviorthesis for the treatment of haemophilic synovitis. Haemophilia 2007; 13 (Suppl 3):32-37.
22. Caviglia HA, Fernandez-Palazzi F, Galatro G, Perez-Bianco R. Chemical synoviorthesiswith rifampicin in haemophilia. Haemophilia 2001; 7 (Suppl 2):26-30.
23. Rodriguez-Merchan E. Synoviorthesis in haemophilia. In Lee C., Berntorp E., Hoots K., editors. Textbook of Hemophilia: Oxford, UK: Blackwell Publishing Ltd. 2007.
24. Medical and Scientific Advisory Council (MASAC) recommendation #194: MASAC recommendations regarding redionuclide synovectomy. 2010. http://www.hemophilia.org/NHFWeb/Resource/Static Pages/menu0/menu5/menu57/176. pdf.[Accessed on 27 October 2010].
25. Rodriguez-Merchan EC Radionuclide synovectomy (radiosynoviorthesis) in hemophilia: averyefficientand single procedure. Semin Thromb Hemost 2003; 29:97-100.
26. Dunn AL, Busch MT, Wyly JB, Abshire TC. Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol. Thromb Haemost 2002; 87:383-393.
27. Turkmen C, Zulflkar B, Taser O, Tokmak H, Kilicoglu O, Mudun A, et al. Radiosynovectomy in hemophilic synovitis: correlation oftherapeutic response and blood-pool changes. Cancer Biother Radiopharm 2005; 20:363-370.
28. Rodriguez-Merchan E, Wiedel J. General principles and indications of synoviorthesis (medical synovectomy) in haemophilia. Haemophilia 2001; 7 (Suppl 2):6-10.
29. Falcón de Vargas A, Fernandez-Palazzi F. Cytogenetic studies in patients with hemophilic hemarthrosis treated by 198Au, 186Rh, and 90Y radioactive synoviorthesis. J Pediatr Orthop B 2000; 9:52-54.
30. Dunn A, Busch M, Wyly J, Abshire TC. Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol. Thromb Haemost 2002; 87:383-393.
31. Dunn A, Manco-Johnson M, Busch M, Balark K, Abshire TC. Leukemia and P32 radionuclide synovectomy for hemophilic arthropathy. J Thromb Haemost 2005; 3:1541-1542.
32. Infante-Rivard C, Rivard GE, Derome F, Cusson A, Winikoff R, Chartrand R, Guay JP. A retrospective cohort study of cancer incidence among patients treated with radiosynoviorthesis. Haemophilia 2012; 18:805-809.
33. De La Corte-Rodriguez H, Rodriguez-Merchan EC, Jimenez-Yuste V. What patient, joint and isotope characteristics influence the response to radiosynovectomy in patients with haemophilia? Haemophilia 2011.
34. Turkmen C. Safety of radiosynovectomy in hemophilic synovitis: it istimeto re-evaluate! J Coagulat Disord 2009:1-8.
35. Journeycake JM, Miller KL, Anderson AM, Buchanan GR, Finnegan M. Arthroscopic synovectomy in children and adolescents with hemophilia. J Pediatr Hematol Oncol 2003; 25:726-731.
36. Dunn AL, Busch MT, Wyly JB, Sullivan KM, Abshire TC. Arthroscopic synovectomyforhemophilicjointdiseasein apediatricpopulation.JPediatr Orthop 2004; 24:414-426.
37. Fernandez-Palazzi F, Rivas S, Viso R, de Bosch NB, de Saez AR, Boadas A. Synovectomy with rifampicine in haemophilic haemarthrosis. Haemophilia 2000; 6:562-565.
38. Fernandez-Palazzi F, Cedeno M, Maldonado JC, Boadas A, De Saez AR, Chacal BF, De Bosch NB. Chemical synoviorthesis with oxytetracycline clorhydrate (Emicine) in recurrent haemarthrosis. Haemophilia 2008; 14:21-24.
39. De La Corte-Rodriguez H, Rodriguez-Merchan EC, Jimenez-Yuste V. Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters. J Thromb Haemost 2011; 9:928-935.
40. De La Corte-Rodriguez H, Rodriguez-Merchan EC, Jimenez-Yuste V. What patient, joint and isotope characteristics influence the response to radiosynovectomy in patients with haemophilia? Haemophilia 2011; 17:e990-e998.
41. De La Corte-Rodriguez H, Rodriguez-Merchan EC, Jimenez-Yuste V. Radiosynovectomy in patients with chronic haemophilic synovitis: when is more than one injection necessary? Eur J Haematol 2011; 86:430-435.
42. Silva M, Luck J, Siegel M. 32P chromic phosphate radiosynovectomy for chronic haemophilia synovitis. Haemophilia 2001; 7:40-49.
43. Verma N, Valentino LA, Chawla A. Arthroscopic synovectomy in haemophilia: indications, technique and results. Haemophilia 2007; 13 (Suppl 3):38-44.